what is the difference between dpp-4 inhibitors and glp-1 analogs dpp-4_inhibitors [TUSOM The effects of GLP-1 analogues,

These include reducing the risk of heart attack and stroke, slowing the decline of kidney function, and reducing the accumulation of damaging fat tissue in the liver

(2015), MCT oil was employed to create a water-in-oil-in-water emulsion, specifically to enhance the stability of curcumin and catechin in beverages

A summary of the gut microbiota features associated with differential response to GLP-1 RA therapy in human studies is provided in Table 2

Given the favorable results from previous studies, a 52-week, multicenter, placebo-controlled, phase II RCT investigating the efficacy and safety of tirzepatide (5, 10, 15 mg/week) in overweight/obese patients with biopsy-confirmed NASH with fibrosis stage 2 or 3 is currently in progress (SYNERGY-NASH